PAPER Abdel-Salam OM
SEARCH RESULTS
330986 RESULTS
PAPER De Vivo G, Gentile V
Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases.
CNS Neurol Disord Drug Targets. 2008 Oct;7(4):370-5. PubMed: 18991665PAPER Balistreri CR, Grimaldi MP, Chiappelli M, Licastro F, Castiglia L, Listì F, Vasto S, Lio D, Caruso C, Candore G
Association between the Polymorphisms of TLR4 and CD14 Genes and Alzheimer's Disease.
Curr Pharm Des. 2008;14(25):2672-7. PubMed: 18991680PAPER Porcellini E, Davis EJ, Chiappelli M, Ianni E, Di Stefano G, Forti P, Ravaglia G, Licastro F
Elevated plasma levels of alpha-1-anti-chymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target.
Curr Pharm Des. 2008;14(26):2659-64. PubMed: 18991685PAPER Lanni C, Racchi M, Uberti D, Mazzini G, Stanga S, Sinforiani E, Memo M, Govoni S
Pharmacogenetics and pharmagenomics, trends in normal and pathological aging studies: focus on p53.
Curr Pharm Des. 2008;14(26):2665-71. PubMed: 18991686PAPER Rishton GM
Small molecules that promote neurogenesis in vitro.
Recent Pat CNS Drug Discov. 2008 Nov;3(3):200-8. PubMed: 18991809PAPER Chopra D, Gulati M, Saluja V, Pathak P, Bansal P
Brain permeable nanoparticles.
Recent Pat CNS Drug Discov. 2008 Nov;3(3):216-25. PubMed: 18991811PAPER Uhl GR, Drgon T, Johnson C, Li CY, Contoreggi C, Hess J, Naiman D, Liu QR
Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.
Ann N Y Acad Sci. 2008 Oct;1141:318-81. PubMed: 18991966PAPER Sakamoto R, Tsuchiya K, Yoshida R, Itoh Y, Furuta N, Kosuga A, Sugai Y, Mimura M
Progressive supranuclear palsy combined with Alzheimer's disease: a clinicopathological study of two autopsy cases.
Neuropathology. 2009 Jun;29(3):219-29. PubMed: 18992014PAPER Ally BA, Gold CA, Budson AE
The picture superiority effect in patients with Alzheimer's disease and mild cognitive impairment.
Neuropsychologia. 2009 Jan;47(2):595-8. PubMed: 18992266PAPER Del Valle J, Duran-Vilaregut J, Manich G, Camins A, Pallàs M, Vilaplana J, Pelegrí C
Time-course of blood-brain barrier disruption in senescence-accelerated mouse prone 8 (SAMP8) mice.
Int J Dev Neurosci. 2009 Feb;27(1):47-52. PubMed: 18992318PAPER Yang L, Lu R, Jiang L, Liu Z, Peng Y
Expression and genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A polymorphism in sporadic Alzheimer's disease in a Southern China population.
Brain Res. 2009 Jan 9;1247:178-81. PubMed: 18992723PAPER Verpillot R, Otto M, Klafki H, Taverna M
Simultaneous analysis by capillary electrophoresis of five amyloid peptides as potential biomarkers of Alzheimer's disease.
J Chromatogr A. 2008 Dec 19;1214(1-2):157-64. PubMed: 18992892PAPER Serdons K, Verduyckt T, Vanderghinste D, Borghgraef P, Cleynhens J, Van Leuven F, Kung H, Bormans G, Verbruggen A
11C-labelled PIB analogues as potential tracer agents for in vivo imaging of amyloid beta in Alzheimer's disease.
Eur J Med Chem. 2009 Apr;44(4):1415-26. PubMed: 18992967PAPER Hashimoto M, Hossain S, Tanabe Y, Kawashima A, Harada T, Yano T, Mizuguchi K, Shido O
The protective effect of dietary eicosapentaenoic acid against impairment of spatial cognition learning ability in rats infused with amyloid beta(1-40).
J Nutr Biochem. 2009 Dec;20(12):965-73. PubMed: 18993051Current Filters
No filters selected